Literature DB >> 18216005

Role of ambulatory blood pressure monitoring in the management of hypertension.

Kathleen Chavanu1, Jennifer Merkel, Allen M Quan.   

Abstract

PURPOSE: The role of ambulatory blood pressure monitoring (ABPM) in the management of hypertension is reviewed.
SUMMARY: ABPM is a fully automated technique in which multiple blood pressure (BP) measurements are taken at regular intervals (usually every 15 to 30 minutes) over a 24-48-hour period, providing a continuous BP record during the patient's normal daily activities. Some experts advocate the use of 24-hour ABPM for all first diagnoses of hypertension and for treatment decision-making. The use of ABPM can improve BP monitoring so that treatment can be optimized more rapidly and more patients can achieve BP targets with appropriate therapy. ABPM may lead to better patient outcomes while requiring less-intensive drug regimens to maintain BP control and reducing treatment costs. By more accurately and reliably measuring BP, especially circadian changes, ABPM has been shown to predict cardiovascular morbidity and mortality and end-organ damage. ABPM is especially beneficial for patients whose hypertension is difficult to diagnose, including the elderly, patients with diabetes, and individuals with resistant hypertension. ABPM is also beneficial for predicting disease severity and prognosis among patients with chronic renal disease, a condition associated with significant cardiovascular risk. Furthermore, ABPM has helped differentiate the 24-hour antihypertensive efficacy of antihypertensive agents among and within differing drug classes and is also useful in drug development for determining optimal dosing.
CONCLUSION: ABPM is an effective method for the accurate diagnosis and management of hypertension and may positively affect clinical outcomes of patients with other risk factors for cardiovascular events.

Entities:  

Mesh:

Year:  2008        PMID: 18216005     DOI: 10.2146/ajhp060663

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  13 in total

Review 1.  Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-05-01

2.  Changes in Central 24-h Ambulatory Blood Pressure and Hemodynamics 12 Months After Bariatric Surgery: the BARIHTA Study.

Authors:  Anna Oliveras; Albert Goday; Laia Sans; Carlos E Arias; Susana Vazquez; David Benaiges; José Manuel Ramon; Julio Pascual
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 3.  Management of Blood Pressure in Patients with Glaucoma.

Authors:  Russell M Levine; Alina Yang; Venkatesh Brahma; James F Martone
Journal:  Curr Cardiol Rep       Date:  2017-09-19       Impact factor: 2.931

4.  A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.

Authors:  S Biesinger; H A Michaels; A S Quadros; Y Qian; A B Rabovsky; R S Badger; T Jalili
Journal:  Eur J Clin Nutr       Date:  2015-06-10       Impact factor: 4.016

Review 5.  Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 years.

Authors:  Alan H Gradman
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.

Authors:  Henry Punzi; Ali Shojaee; William F Waverczak; Jen-Fue Maa
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-01       Impact factor: 3.738

7.  Racial differences in nocturnal dipping status in diabetic kidney disease: Results from the STOP-DKD (Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease) study.

Authors:  Leah L Zullig; Clarissa J Diamantidis; Hayden B Bosworth; Manjushri V Bhapkar; Huiman Barnhart; Megan M Oakes; Jane F Pendergast; Julie J Miller; Uptal D Patel
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-20       Impact factor: 3.738

8.  Seated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus.

Authors:  Dean J Kereiakes; Joel M Neutel
Journal:  Drugs R D       Date:  2011-09-01

9.  Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals.

Authors:  Jan Basile
Journal:  Integr Blood Press Control       Date:  2010-06-21

10.  Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination.

Authors:  Henry A Punzi
Journal:  Integr Blood Press Control       Date:  2011-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.